Vaccine Weekly
Susan Hasty, Publisher
Table of Contents . . . October 22nd, 2003
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Vaccine Weekly | Other Publications
Malaria Vaccine - Lipid metabolism is possible new target for malaria chemotherapy
Smallpox Vaccine - Clonal vaccinia virus grown in cell culture as a new smallpox vaccine
Biomimetics - Biomimetic design in microparticulate vaccines reviewed
Cancer Vaccine - Frontier of tumor vaccines has gone from gene therapy to dendritic cells
Pneumococcal Vaccine - Genetic variation influences the B-cell response to pneumococcal vaccine
Tumor Markers - Tumor antigens and markers in renal cell carcinoma reviewed
Anthrax - Antibodies demonstrate efficacy against anthrax spore challenge
Anthrax - Antidotes to bioterror agent slow to arrive
Biodefense - Government reports "tremendous progress" in research
Cancer Immunotherapy - Electroporated dendritic cells are powerful cytotoxic T lymphocyte stimulators
Cancer Vaccine - Melanoma-associated antigen DNA vaccine invokes anticancer protection
Childhood Immunization - Have parents behaved irrationally towards MMR?
Dendritic-Cell Vaccine - Genetic tagging shows longevity of antigen-presenting dendritic cells
Dendritic-Cell Vaccine - Highly potent dendritic cell-tumor cell hybrid vaccines developed
Dengue Fever - Dengue fever vaccine best delivered at one year of age
Drug Delivery - European patent granted for aerosol formulations
Facilities - NIAID funds construction of biosafety laboratories
Gene Therapy - High-level of polyclonal antibodies generated by genetic immunization
Gene Therapy - Molecular basis for gene vaccines against autoimmune disease developed
Genomics - Activity of ABthrax described at ICAAC
Grants - Biotechnology company receives grants from NIAID, NIAAA
Hepatitis - Panel: Long-term efficacy of hepatitis A vaccination means no need for booster
Infectious Disease - TIGR and NIAID sign $65 million microbial sequencing contract
Influenza - Flu shot supply expected to be plentiful
Influenza - Nasty Australian flu bug has U.S. officials worried
Melanoma - Apoptotic tumor cells prime immune responder cells against cancer
Meningococcal Disease - New, affordable vaccine stops meningitis
Pancreatic Cancer - Data from phase I trial of Oncophage cancer vaccine reported
Personnel - Jerald Sadoff, MD, named CEO of TB vaccine effort
Pneumonia - Pneumococcal vaccine significantly reduces disease in South African children
Public Health - Health officials express concern about flu complacency
Public Health - National influenza recommendations updated to include FluMist
Research Funding - U.S. awards $81 million for HIV vaccine development
Respiratory Syncytial Virus - Eosinophilia linked to expression of substance P
SARS - New pact signed to develop vaccine for severe acute respiratory syndrome
SARS - Virus can change quickly and unpredictably, analysis indicates
Smallpox - Project aims to make inoculations safe by "leashing" current vaccine virus
Smallpox - Study of earlier vaccination during outbreak reveals no link to heart problems
Smallpox Vaccine - Duration of antiviral immunity after smallpox vaccination investigated
Streptococcus Vaccine - Vaccine of Streptococcus mutans antigens induces immune response
Survival & Mortality - TP10 development reinstated; cardiovascular surgical trial to be initiated
Toxoplasmosis - Long-term protective immune response elicited by Toxoplasma gondii vaccine
Tumor Antigens - Phage-display improved human cDNA library screening for breast cancer antigens
Vaccine Development - Multigene DNA prime-boost vaccines for SHIV89.6P developed
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
